| RS1311444460 |
CYP11B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Corticosterone 18-monooxygenase deficiency, Corticosterone methyloxidase type 2 deficiency |
| RS1311447368 |
HOGA1
|
Health Risk |
Pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS1311451829 |
CNGA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS1311474144 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1311482428 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1311529652 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1311530268 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1311551510 |
TMEM237
|
Health Risk |
Pathogenic |
Joubert syndrome 14, Joubert syndrome 14 |
| RS1311592052 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1311596702 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus, Transient Neonatal Diabetes |
| RS1311614264 |
MINPP1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia, type 16 |
| RS1311636142 |
MUSK
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS1311655109 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1311659158 |
ARG1
|
Health Risk |
Likely pathogenic |
Arginase deficiency, Arginase deficiency |
| RS1311664031 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1311664509 |
WDR37
|
Health Risk |
Likely pathogenic |
Neurooculocardiogenitourinary syndrome, Neurooculocardiogenitourinary syndrome |
| RS1311681895 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, PALB2-related cancer predisposition |
| RS1311699085 |
BBS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS1311718055 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1311730265 |
PHF21A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1311737177 |
TBCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS1311747266 |
SLC4A11
|
Health Risk |
Pathogenic |
Corneal dystrophy-perceptive deafness syndrome, Corneal dystrophy-perceptive deafness syndrome |
| RS1311804361 |
PTCH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1311814991 |
CFH
|
Health Risk |
Pathogenic |
Hemolytic uremic syndrome, atypical |
| RS1311819000 |
POPDC3
|
Health Risk |
Pathogenic |
Muscular dystrophy, limb-girdle |
| RS1311822511 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1311829327 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1311844326 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1311845746 |
COMP
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1311857509 |
NPR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS1311863343 |
VAMP1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1311880928 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS13118928 |
HHIP
|
Health Risk |
association |
Chronic obstructive pulmonary disease, biomass related |
| RS1311903314 |
HEXB
|
Health Risk |
Likely pathogenic |
Sandhoff disease, Sandhoff disease |
| RS1311908399 |
DUOX2
|
Health Risk |
Likely pathogenic |
— |
| RS1311909367 |
SNX14
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 20, Autosomal recessive spinocerebellar ataxia 20 |
| RS1311913891 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS1311916818 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS1311922451 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1311924956 |
COG4
|
Health Risk |
Likely pathogenic |
COG4-congenital disorder of glycosylation, COG4-congenital disorder of glycosylation |
| RS1311932817 |
CD3D
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency 19, Immunodeficiency 19 |
| RS1311935185 |
LRP5
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta, 6 conditions |
| RS1311945646 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS1311967606 |
ALOXE3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive congenital ichthyosis 2, Lamellar ichthyosis |
| RS1311980539 |
MYO3A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS1311982393 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1311986203 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS1312002847 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal dominant form |
| RS1312009126 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS1312027182 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 9, Cardiovascular phenotype |
| RS1312031160 |
LCT
|
Health Risk |
Likely pathogenic |
Congenital lactase deficiency, Congenital lactase deficiency |
| RS1312042895 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS1312054803 |
POU1F1
|
Health Risk |
Pathogenic |
— |
| RS1312069480 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1312078830 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
GABRA1-related disorder, Inborn genetic diseases |
| RS1312090680 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type A |
| RS1312117773 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1312118611 |
USH1C
|
Health Risk |
Pathogenic |
— |
| RS1312150142 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS1312169516 |
POLR2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities |
| RS1312172811 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1312183934 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1312200383 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1312200609 |
MFSD8
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1312209529 |
SLC52A2
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 2, Brown-Vialetto-van Laere syndrome 2 |
| RS1312220322 |
SON
|
Health Risk |
Conflicting classifications of pathogenicity |
ZTTK syndrome, ZTTK syndrome |
| RS1312234258 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor I deficiency, Age related macular degeneration 13 |
| RS1312256471 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS1312261586 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1312264385 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS1312285586 |
IFNAR2
|
Health Risk |
Pathogenic |
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection, Immunodeficiency 45 |
| RS1312290440 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS1312300020 |
MMP21
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS1312320956 |
ADA
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1312334046 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1312336997 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS1312347909 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1312351030 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Heimler syndrome 1 |
| RS1312358074 |
PKD1L1
|
Health Risk |
Pathogenic |
— |
| RS1312374123 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1312378621 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1312379259 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS1312379571 |
MANBA
|
Health Risk |
Likely pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1312383000 |
EVC
|
Health Risk |
Pathogenic/Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1312396424 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrin deficiency, Citrullinemia |
| RS1312402189 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1312406661 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS1312413528 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1312414434 |
CYB5R3
|
Health Risk |
Pathogenic |
— |
| RS1312420010 |
DST
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS1312425146 |
VPS13A
|
Health Risk |
Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1312425649 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, DICER1-related tumor predisposition |
| RS1312425985 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1312429867 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS1312431639 |
PSMB8
|
Health Risk |
Pathogenic |
Proteosome-associated autoinflammatory syndrome, Proteosome-associated autoinflammatory syndrome |
| RS1312438512 |
RARS1
|
Health Risk |
Pathogenic |
— |
| RS1312477726 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS1312486904 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS1312494071 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1312504115 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |